Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Molecular & Cellular Oncology
|
September 26, 2018
One gene to rule them all…and in the darkness bind them
Konstantinos V Floros, Anthony C Faber
Theranostics
|
May 4, 2018
OVOL2 in metastasis prevention in NPC
Kyung-A Song, Anthony C Faber
Cell Cycle (Georgetown, Tex.)
|
December 25, 2007
Inhibition of cyclin-dependent kinase-2 induces apoptosis in human diffuse large B-cell lymphomas
Anthony C Faber, Thomas C Chiles
Journal of Thoracic Disease
|
August 3, 2019
Epithelial-to-mesenchymal transition and drug resistance: transitioning away from death
Kyung-A Song, Anthony C Faber
International Journal of Oncology
|
November 8, 2006
Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: evidence for a novel mechanism involving inhibition of BCL6 signaling
Anthony C Faber, Thomas C Chiles
Journal of Thoracic Disease
|
October 22, 2019
Respecting your elders: osimertinib demonstrates preferential activity in elderly patients with T790M positive non-small cell lung cancers
Hiromichi Ebi, Sosipatros Boikos, Anthony C Faber
Oncoscience
|
September 21, 2018
BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer
Timothy L Lochmann, Ynes M Bouck, Anthony C Faber
Cell Cycle (Georgetown, Tex.)
|
February 18, 2010
Differences underlying EGFR and HER2 oncogene addiction
Anthony C Faber, Kwok-Kin Wong, Jeffrey A Engelman
Cell Cycle (Georgetown, Tex.)
|
February 5, 2010
Cyclins D3 and E go hand in hand with Cdk4/6 in diffuse large B-cell lymphoma
Thomas D Gilmore, Ryan C Thompson, Anthony C Faber
Cancer Discovery
|
April 22, 2015
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Aaron N Hata, Jeffrey A Engelman, Anthony C Faber
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Molecular & Cellular Oncology
|
September 26, 2018
One gene to rule them all…and in the darkness bind them
Konstantinos V Floros, Anthony C Faber
Theranostics
|
May 4, 2018
OVOL2 in metastasis prevention in NPC
Kyung-A Song, Anthony C Faber
Cell Cycle (Georgetown, Tex.)
|
December 25, 2007
Inhibition of cyclin-dependent kinase-2 induces apoptosis in human diffuse large B-cell lymphomas
Anthony C Faber, Thomas C Chiles
Journal of Thoracic Disease
|
August 3, 2019
Epithelial-to-mesenchymal transition and drug resistance: transitioning away from death
Kyung-A Song, Anthony C Faber
International Journal of Oncology
|
November 8, 2006
Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: evidence for a novel mechanism involving inhibition of BCL6 signaling
Anthony C Faber, Thomas C Chiles
Journal of Thoracic Disease
|
October 22, 2019
Respecting your elders: osimertinib demonstrates preferential activity in elderly patients with T790M positive non-small cell lung cancers
Hiromichi Ebi, Sosipatros Boikos, Anthony C Faber
Oncoscience
|
September 21, 2018
BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer
Timothy L Lochmann, Ynes M Bouck, Anthony C Faber
Cell Cycle (Georgetown, Tex.)
|
February 18, 2010
Differences underlying EGFR and HER2 oncogene addiction
Anthony C Faber, Kwok-Kin Wong, Jeffrey A Engelman
Cell Cycle (Georgetown, Tex.)
|
February 5, 2010
Cyclins D3 and E go hand in hand with Cdk4/6 in diffuse large B-cell lymphoma
Thomas D Gilmore, Ryan C Thompson, Anthony C Faber
Cancer Discovery
|
April 22, 2015
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Aaron N Hata, Jeffrey A Engelman, Anthony C Faber
Page
of 8